Osiris Therapeutics(美國(guó))

Osiris Therapeutics

美國(guó)OsirisTherapeuticswww.osiristx.com美國(guó)Osiris關(guān)注與間質(zhì)干細(xì)胞地位（MSC）的技術(shù)，職前臨床，在疾病的動(dòng)物模型，并在診所也。近年來，該公司贊助了一些臨床試驗(yàn)，以評(píng)估產(chǎn)品的安全性和有效性。OsirisTherapeutics,Inc.hasfocusedontheadvancementofmesenchymalstemcell(MSC)technologie sbothpre-clinically,inanimalmodelsofdisease,andalsointheclinic.Inrecentyears,theCompanyhassponsoredanumberofclinicaltrialstoevaluateproductsafetyandefficacy.Theprimarythrustofthenear-termbusinessstrategyrevolvesaroundtheclinicaldevelopmentofproductcandidatesinavarietyofindications.Theinflammatoryprogramfocusesonprovidingsupportforbonemarrowtransplantationafterchemotherapyorradiationtherapy.Thegoalistotreatgraftversushostdisease(GvHD),alife-threateningcomplicationfollowingthereceiptofbonemarrowfromanotherindividual.ThecardiacprogramfocusesonMSCstoimproveheartfunctionfollowingmyocardialinfarction(MI)andtopreventprogressiontocongestive